Proteomic study on the protective mechanism of fibroblast growth factor 21 to ischemia-reperfusion injury
Proteomic study on the protective mechanism of fibroblast growth factor 21 to ischemia-reperfusion injury
复制标题
成纤维细胞生长因子21对缺血再灌注损伤保护机制的蛋白质组学研究
DOI:
10.1139/cjpp-2012-0441
复制
发表时间:
2013-11-01
影响因子:
2.1
通讯作者:
Li, Xiao Kun
中科院分区:
文献类型:
--
作者:
Cong, Wei-Tao;Ling, Jin;Li, Xiao Kun
Fibroblast growth factor (FGF)-21 is a novel regulator of insulin-independent glucose transport in 3T3-L1 adipocytes and has glucose and triglyceride lowering effects in rodent models of diabetes. In this study, we found that FGF-21 can significantly attenuate ischemia-reperfusion (I/R) induced damage in H9c2 cells (rat heart). However, it is unclear which signal transduction pathway is involved in the cardioprotective effect of FGF-21. Thus, this study was designed to investigate the potential mechanism induced by FGF-21. The results showed that FGF-21 treatment prevented the oxidative stress and apoptosis associated with I/R damage by reducing the levels of superoxide anions, inhibiting glycogen synthase kinase (GSK) 3 beta by activating Akt phosphorylation, and recovering the levels of ATP synthase pyruvate kinase isozymes M1 and protein kinase C, thereby improving energy supply. In summary, we conclude that FGF-21 protects H9c2 cells against I/R injury mainly through the Akt-GSK-3 beta-caspase-3 dependent pathway, preventing oxidative stress, and recovery of the energy supply.